Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva Test, CoviSafe™
Enzon Pharmaceuticals, Inc.
-
December 8, 2020
0
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
Enzon Pharmaceuticals, Inc.
-
October 20, 2020
0
Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial
Enzon Pharmaceuticals, Inc.
-
September 25, 2020
0
Biotech News
Home
Biotech News
Page 2
Biotech News
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its...
Enzon Pharmaceuticals, Inc.
-
August 17, 2020
0
Biotech News
CytoDyn Submits its Top-line Report from its Phase 2 COVID-19 Trial...
CytoDyn Inc.
-
August 17, 2020
0
Biotech News
Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3...
Algernon Pharmaceuticals Inc.
-
August 13, 2020
0
Biotech News
Cognetivity Neurosciences presents at virtual Alzheimer’s Association International Conference (AAIC) 2020
Cognetivity Neurosciences Ltd.
-
August 13, 2020
0
1
2
3
...
22
Page 2 of 22
- Advertisement -
APPLE
Novavax Receives $388 Million COVID-19 Funding, Reports Q1 Results
Cognetivity Neurosciences Ltd.
-
May 27, 2020
0
Biotech Insights
Novavax (NASDAQ: NVAX), a late-stage biotechnology company based in Maryland, announced a series of positive developments on May 11th that caused its stock price...
RECENT POSTS
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Cognetivity Neurosciences Ltd.
-
December 22, 2020
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes...
Cognetivity Neurosciences Ltd.
-
December 15, 2020
Ahead of Vaccine, Fast, Affordable Testing for COVID is Still Essential to Limiting Spread
Cognetivity Neurosciences Ltd.
-
December 10, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Cognetivity Neurosciences Ltd.
-
December 8, 2020
Edit with Live CSS
